StockData
Ingevity Corp logo

Ingevity Corp (NGVT) stock

NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3077% above fair value
$60.02−1.70 (-2.75%)

Close on Nov 16, 2026Market cap $2.06BP/E 40.8Yield –

Ingevity cash

Cash and short-term investments held at the end of each period.

Ingevity's cash was $97.40M at Jun 30, 2026. For fiscal 2025 it was $78.10M, up 14.9% from the year before. Over ten years it grew 9.3% a year on average. The highest annual figure on record is $280.70M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.10M+14.9%
FY2024Dec 31, 2024$68.00M-29.1%
FY2023Dec 31, 2023$95.90M+13.8%
FY2022Dec 31, 2022$84.30M-70.0%
FY2021Dec 31, 2021$280.70M+7.6%
FY2020Dec 31, 2020$260.80M+303.7%
FY2019Dec 31, 2019$64.60M-17.0%
FY2018Dec 31, 2018$77.80M-11.5%
FY2017Dec 31, 2017$87.90M+188.2%
FY2016Dec 31, 2016$30.50M-4.7%
FY2015Dec 31, 2015$32.00M+60.8%
FY2014Dec 31, 2014$19.90M+73.0%
FY2013Dec 31, 2013$11.50M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$97.40M+26.7%
Q1 FY2026Mar 31, 2026$95.40M+33.4%
Q4 FY2025Dec 31, 2025$78.10M+14.9%
Q3 FY2025Sep 30, 2025$83.40M-38.5%
Q2 FY2025Jun 30, 2025$76.90M-28.4%
Q1 FY2025Mar 31, 2025$71.50M-19.2%
Q4 FY2024Dec 31, 2024$68.00M-29.1%
Q3 FY2024Sep 30, 2024$135.50M+60.4%
Q2 FY2024Jun 30, 2024$107.40M+57.9%
Q1 FY2024Mar 31, 2024$88.50M+13.6%
Q4 FY2023Dec 31, 2023$95.90M+13.8%
Q3 FY2023Sep 30, 2023$84.50M+16.9%
Q2 FY2023Jun 30, 2023$68.00M-48.2%
Q1 FY2023Mar 31, 2023$77.90M-65.0%
Q4 FY2022Dec 31, 2022$84.30M-70.0%
Q3 FY2022Sep 30, 2022$72.30M-73.2%
Q2 FY2022Jun 30, 2022$131.30M-43.7%
Q1 FY2022Mar 31, 2022$222.60M-6.4%
Q4 FY2021Dec 31, 2021$280.70M+7.6%
Q3 FY2021Sep 30, 2021$269.40M+35.9%
Q2 FY2021Jun 30, 2021$233.30M+31.4%
Q1 FY2021Mar 31, 2021$237.80M-21.4%
Q4 FY2020Dec 31, 2020$260.80M+303.7%
Q3 FY2020Sep 30, 2020$198.20M+162.2%
Q2 FY2020Jun 30, 2020$177.60M+233.2%
Q1 FY2020Mar 31, 2020$302.70M+666.3%
Q4 FY2019Dec 31, 2019$64.60M-17.0%
Q3 FY2019Sep 30, 2019$75.60M+31.5%
Q2 FY2019Jun 30, 2019$53.30M-35.8%
Q1 FY2019Mar 31, 2019$39.50M-52.4%
Q4 FY2018Dec 31, 2018$77.80M-11.5%
Q3 FY2018Sep 30, 2018$57.50M-18.1%
Q2 FY2018Jun 30, 2018$83.00M+104.4%
Q1 FY2018Mar 31, 2018$83.00M+179.5%
Q4 FY2017Dec 31, 2017$87.90M+188.2%
Q3 FY2017Sep 30, 2017$70.20M+159.0%
Q2 FY2017Jun 30, 2017$40.60M–
Q1 FY2017Mar 31, 2017$29.70M–
Q4 FY2016Dec 31, 2016$30.50M–
Q3 FY2016Sep 30, 2016$27.10M–

More Ingevity figures

See a number that looks wrong?